ADVISORY: W&M Democrats to Host ‘Trading Views’ TPP Hearing on Access to Medicines

Webp 20edited

ADVISORY: W&M Democrats to Host ‘Trading Views’ TPP Hearing on Access to Medicines

The following press release was published by the U.S. Congress Committee on Ways and Means on Dec. 7, 2015. It is reproduced in full below.

WASHINGTON, DC - Ways and Means Committee Ranking Member Sander Levin (D-MI), along with the Committee’s Democratic members, tomorrow will continue “Trading Views: Real Debates on Key Issues in TPP " with a session focusing on access to medicines in TPP. The Committee’s Democratic trade staff have prepared an issue analysis paper [PDF here] that will be distributed at the hearing.

WHAT: “Trading Views: Real Debates on Key Issues in TPP" hearing on access to medicines

WITNESSES:

Stephen Ezell, VP of Global Innovation Policy, Information Technology and Innovation Foundation

Rohit Malpani, Director of Policy and Analysis, Médecins Sans Frontières Access Campaign

Joseph Damond, Senior VP for International Affairs, Biotechnology Industry Organization (BIO)

Peter Maybarduk, Director, Public Citizen Global Access to Medicines Program

WHEN: 2:00-3:30 pm on Tuesday, December 8

WHERE: Cannon 210 (House Budget Committee hearing room)

Oral testimony at this hearing will be from the invited witnesses only. However, any individual or organization may submit a written statement for consideration by the Committee’s Democratic Members.

Details for Submission of Written Comments:

To submit a submission, please email W&MDem.Submission@mail.house.gov

ATTACH your submission as a Word document, in compliance with the formatting requirements listed below, by the close of business on Tuesday, Dec. 15, 2015.

Formatting Requirements:

1. Include the topic of the hearing or forum in the subject line of the email (i.e. “Testimony for environment hearing").

2. All submissions and supplementary materials must be submitted in a single document via email, provided in Word format and must not exceed a total of 10 pages.

3. All submissions must include a list of all clients, persons and/or organizations on whose behalf the witness appears. The name, company, address, telephone, and fax numbers of each witness must be included in the body of the email. Please exclude any personal identifiable information in the attached submission.

4. Failure to follow the formatting requirements may result in the exclusion of a submission.

Source: U.S. Congress Committee on Ways and Means

More News